Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q2 2025 (June 30)12holders
1new positions
1sold out
$1.94avg. 13F price*
At the end of Q2 2025, 12 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were UBS Group AG ($15K), Federation des caisses Desjardins du Quebec ($7K) and GAMMA Investing LLC ($4K).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $396 |
| Exits | 1 | $57K |
All 13F filers, Q1 2025 → Q2 2025: 12,357 shares bought and 23,068 shares sold, net −10,711 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| UBS Group AG | 0.00% | Add +266166.7% | 7,988 | $15K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 3,388 | $7K |
| GAMMA Investing LLC | 0.00% | Reduce -42.2% | 2,061 | $4K |
| SBI Securities Co., Ltd. | 0.00% | Add +39980.0% | 2,004 | $4K |
| Morgan Stanley | 0.00% | Add +13761.5% | 1,802 | $3K |
| Rhumbline Advisers | 0.00% | Add +27.4% | 1,768 | $3K |
| Bank of America Corp. | 0.00% | No change | 303 | $588 |
| Raymond James Financial Inc. | 0.00% | New | 204 | $396 |
| Group One Trading LLC | 0.00% | Reduce -50.0% | 11 | $21 |
| Financial Management Professionals, Inc. | 0.00% | Reduce -80.8% | 9 | $17 |
| Vermillion Wealth Management, Inc. | 0.00% | No change | 2 | $4 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.